EUR 234.5
(0.51%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 16.07 Billion EUR | 3.06% |
2022 | 15.59 Billion EUR | 26.94% |
2021 | 12.28 Billion EUR | 44.64% |
2020 | 8.49 Billion EUR | -21.54% |
2019 | 10.82 Billion EUR | 60.56% |
2018 | 6.74 Billion EUR | 15.13% |
2017 | 5.85 Billion EUR | 40.06% |
2016 | 4.18 Billion EUR | 4.21% |
2015 | 4.01 Billion EUR | 21.03% |
2014 | 3.31 Billion EUR | 16.81% |
2013 | 2.83 Billion EUR | 1.95% |
2012 | 2.78 Billion EUR | 19.91% |
2011 | 2.32 Billion EUR | 7.5% |
2010 | 2.15 Billion EUR | 17.84% |
2009 | 1.83 Billion EUR | 4.76% |
2008 | 1.74 Billion EUR | 4.49% |
2007 | 1.67 Billion EUR | 6.85% |
2006 | 1.56 Billion EUR | 12.74% |
2005 | 1.38 Billion EUR | 1.98% |
2004 | 1.36 Billion EUR | 6.28% |
2003 | 1.28 Billion EUR | 0.45% |
2002 | 1.27 Billion EUR | 8.77% |
2001 | 1.17 Billion EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 8.4 Billion EUR | 0.0% |
2023 Q2 | 8.23 Billion EUR | 0.0% |
2023 Q4 | 7.84 Billion EUR | 0.0% |
2023 FY | 16.07 Billion EUR | 3.06% |
2022 Q4 | 7.86 Billion EUR | 0.0% |
2022 FY | 15.59 Billion EUR | 26.94% |
2022 Q2 | 7.72 Billion EUR | 0.0% |
2021 Q2 | 5.38 Billion EUR | 0.0% |
2021 Q4 | 6.89 Billion EUR | 0.0% |
2021 FY | 12.28 Billion EUR | 44.64% |
2020 Q4 | 4.94 Billion EUR | 0.0% |
2020 Q2 | 3.54 Billion EUR | 0.0% |
2020 FY | 8.49 Billion EUR | -21.54% |
2019 Q4 | 5.33 Billion EUR | 0.0% |
2019 Q2 | 5.48 Billion EUR | 0.0% |
2019 FY | 10.82 Billion EUR | 60.56% |
2018 Q4 | 3.83 Billion EUR | 0.0% |
2018 FY | 6.74 Billion EUR | 15.13% |
2018 Q2 | 2.91 Billion EUR | 0.0% |
2017 FY | 5.85 Billion EUR | 40.06% |
2017 Q2 | 2.26 Billion EUR | 0.0% |
2017 Q4 | 3.59 Billion EUR | 0.0% |
2016 FY | 4.18 Billion EUR | 4.21% |
2016 Q2 | 2.13 Billion EUR | 0.0% |
2016 Q4 | 2.04 Billion EUR | 0.0% |
2015 Q2 | 2.04 Billion EUR | 0.0% |
2015 FY | 4.01 Billion EUR | 21.03% |
2015 Q4 | 1.97 Billion EUR | 0.0% |
2014 Q2 | 1.59 Billion EUR | 0.0% |
2014 FY | 3.31 Billion EUR | 16.81% |
2014 Q4 | 1.71 Billion EUR | 0.0% |
2013 Q2 | 1.44 Billion EUR | 0.0% |
2013 FY | 2.83 Billion EUR | 1.95% |
2013 Q4 | 1.38 Billion EUR | 0.0% |
2012 Q4 | 695.93 Million EUR | 0.0% |
2012 Q2 | 695.93 Million EUR | 0.0% |
2012 Q1 | 695.93 Million EUR | 19.91% |
2012 FY | 2.78 Billion EUR | 19.91% |
2012 Q3 | 695.93 Million EUR | 0.0% |
2011 Q2 | 580.36 Million EUR | 0.0% |
2011 Q3 | 580.36 Million EUR | 0.0% |
2011 Q4 | 580.36 Million EUR | 0.0% |
2011 FY | 2.32 Billion EUR | 7.5% |
2011 Q1 | 580.36 Million EUR | 7.5% |
2010 Q3 | 539.88 Million EUR | 0.0% |
2010 FY | 2.15 Billion EUR | 17.84% |
2010 Q4 | 539.88 Million EUR | 0.0% |
2010 Q2 | 539.88 Million EUR | 0.0% |
2010 Q1 | 539.88 Million EUR | 17.84% |
2009 Q1 | 458.16 Million EUR | 4.76% |
2009 Q2 | 458.16 Million EUR | 0.0% |
2009 Q3 | 458.16 Million EUR | 0.0% |
2009 Q4 | 458.16 Million EUR | 0.0% |
2009 FY | 1.83 Billion EUR | 4.76% |
2008 Q3 | 437.32 Million EUR | 0.0% |
2008 Q2 | 437.32 Million EUR | 0.0% |
2008 Q1 | 437.32 Million EUR | 4.49% |
2008 FY | 1.74 Billion EUR | 4.49% |
2008 Q4 | 437.32 Million EUR | 0.0% |
2007 FY | 1.67 Billion EUR | 6.85% |
2007 Q4 | 418.53 Million EUR | 0.0% |
2007 Q3 | 418.53 Million EUR | 0.0% |
2007 Q2 | 418.53 Million EUR | 0.0% |
2007 Q1 | 418.53 Million EUR | 6.85% |
2006 Q1 | 391.72 Million EUR | 12.74% |
2006 Q4 | 391.72 Million EUR | 0.0% |
2006 Q3 | 391.72 Million EUR | 0.0% |
2006 Q2 | 391.72 Million EUR | 0.0% |
2006 FY | 1.56 Billion EUR | 12.74% |
2005 Q4 | 347.44 Million EUR | 0.0% |
2005 Q2 | 347.44 Million EUR | 0.0% |
2005 FY | 1.38 Billion EUR | 1.98% |
2005 Q1 | 347.44 Million EUR | 1.98% |
2005 Q3 | 347.44 Million EUR | 0.0% |
2004 FY | 1.36 Billion EUR | 6.28% |
2004 Q3 | 340.69 Million EUR | 0.0% |
2004 Q1 | 340.69 Million EUR | 6.28% |
2004 Q2 | 340.69 Million EUR | 0.0% |
2004 Q4 | 340.69 Million EUR | 0.0% |
2003 Q1 | 320.56 Million EUR | 0.45% |
2003 Q4 | 320.56 Million EUR | 0.0% |
2003 FY | 1.28 Billion EUR | 0.45% |
2003 Q3 | 320.56 Million EUR | 0.0% |
2003 Q2 | 320.56 Million EUR | 0.0% |
2002 Q3 | 319.12 Million EUR | 0.0% |
2002 FY | 1.27 Billion EUR | 8.77% |
2002 Q2 | 319.12 Million EUR | 0.0% |
2002 Q1 | 319.12 Million EUR | 8.77% |
2002 Q4 | 319.12 Million EUR | 0.0% |
2001 FY | 1.17 Billion EUR | 0.0% |
2001 Q3 | 293.39 Million EUR | 0.0% |
2001 Q2 | 293.39 Million EUR | 0.0% |
2001 Q1 | 293.39 Million EUR | 0.0% |
2001 Q4 | 293.39 Million EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Crossject Société Anonyme | -6.13 Million EUR | 262039.69% |
Safe Orthopaedics SA | 4.1 Million EUR | -391278.471% |
Spineway SA | 1.55 Million EUR | -1036005.738% |
Amplitude Surgical SA | 37.2 Million EUR | -43094.28% |
Sartorius Stedim Biotech S.A. | 1.23 Billion EUR | -1202.797% |
bonyf N.V. | 26.41 Thousand EUR | -60838849.042% |